Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Company, F."'
Publikováno v:
In Biochemical Pharmacology August 2021 190
Publikováno v:
مجله دانشگاه علوم پزشکی گرگان, Vol 12, Iss 3, Pp 18-23 (2010)
Background and Objective: Respiratory distress syndrome is the most important lung problem during the neonatal period. Although the benefits of antenatal corticosteroids in neonates with a gestational age of less than 34 weeks have been demonstrated,
Externí odkaz:
https://doaj.org/article/ad2085d0c60b48bca43a1222c38b63b8
Publikováno v:
In Fuzzy Sets and Systems 2011 166(1):56-64
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Charles K. Fisher, Aaron M. Smith, Jonathan R. Walsh, Coalition Against Major Diseases, Abbott, Alliance for Aging Research, Alzheimer’s Association, Alzheimer’s Foundation of America, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Critical Path Institute, CHDI Foundation, Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Forest Research Institute, Genentech, Inc., GlaxoSmithKline, Johnson & Johnson, National Health Council, Novartis Pharmaceuticals Corporation, Parkinson’s Action Network, Parkinson’s Disease Foundation, Pfizer, Inc., sanofi-aventis. Collaborating Organizations: Clinical Data Interchange Standards Consortium (CDISC), Ephibian, Metrum Institute.
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-14 (2019)
Scientific Reports
Scientific Reports
Most approaches to machine learning from electronic health data can only predict a single endpoint. The ability to simultaneously simulate dozens of patient characteristics is a crucial step towards personalized medicine for Alzheimer’s Disease. He
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c101fc21a20ed8ce94b12dcb5a5ec42a
https://doi.org/10.1038/s41598-019-49656-2
https://doi.org/10.1038/s41598-019-49656-2
Autor:
Fisher, Charles K, Smith, Aaron M, Walsh, Jonathan R, Coalition Against Major Diseases, Abbott, Alliance for Aging Research, Alzheimer’s Association, Alzheimer’s Foundation of America, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Critical Path Institute, CHDI Foundation, Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Forest Research Institute, Genentech, Inc., GlaxoSmithKline, Johnson & Johnson, National Health Council, Novartis Pharmaceuticals Corporation, Parkinson’s Action Network, Parkinson’s Disease Foundation, Pfizer, Inc., sanofi-aventis. Collaborating Organizations: Clinical Data Interchange Standards Consortium (CDISC), Ephibian, Metrum Institute.
Publikováno v:
Scientific reports, vol 9, iss 1
Most approaches to machine learning from electronic health data can only predict a single endpoint. The ability to simultaneously simulate dozens of patient characteristics is a crucial step towards personalized medicine for Alzheimer's Disease. Here
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::b741e1b4d91874089ef97d675f158f16
https://escholarship.org/uc/item/9gr9344s
https://escholarship.org/uc/item/9gr9344s
Autor:
CASTRO-COMPANY, F.1 fracasco@mat.upv.es, TIRADO, P.2 pedtipe@mat.upv.es
Publikováno v:
Iranian Journal of Fuzzy Systems. Jun2016, Vol. 13 Issue 3, p143-164. 6p.
Autor:
Zelada Rodríguez, Marco Antonio, Cerdà Mas, Georgina, García Ortiz de Uriarte, Laura, Martí Company, F. Xavier, Ronquillo Moreno, Natalia, Rodríguez González, Daniel
Publikováno v:
In Medicina Clinica 24 April 2020 154(8):301-304
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
AIP Conference Proceedings; 11/6/2008, Vol. 1060 Issue 1, p129-132, 4p, 2 Graphs